Overcoming multidrug resistance through inhalable siRNA nanoparticles-decorated porous microparticles based on supercritical fluid technology

References

• SpiroSGTannerNTSilvestriGALung cancer: progress in diagnosis, staging and therapyRespirology2010151445020199634
   PubMed Web of Science ®Google Scholar
• BergerWSetinekUHollausPMultidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implicationsJ Cancer Res Clin Oncol2005131635536315856298
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKDJemalACancer statistics, 2017CA Cancer J Clin201767173028055103
   PubMed Web of Science ®Google Scholar
• WagnerTDYangGYThe role of chemotherapy and radiation in the treatment of locally advanced non-small cell lung cancer (NSCLC)Curr Drug Targets2010111677319839925
   PubMed Web of Science ®Google Scholar
• KatzelJAFanucchiMPLiZZjLRecent advances of novel targeted therapy in non-small cell lung cancerJ Hematol Oncol200921219159467
   PubMedGoogle Scholar
• KankalaRKTsaiP-YKuthatiYWeiP-RLiuC-LLeeC-HOvercoming multidrug resistance through co-delivery of ROS-generating nano-machinery in cancer therapeuticsJ Mater Chem B20175715071517
   PubMed Web of Science ®Google Scholar
• WuHHaitWNYangJMSmall interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cellsCancer Res20036371515151912670898
   PubMed Web of Science ®Google Scholar
• ChenZSTiwariAKMultidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseasesFebs J2011278183226324521740521
   PubMed Web of Science ®Google Scholar
• KankalaRKLiuC-GChenA-ZOvercoming multidrug resistance through the synergistic effects of hierarchical pH-sensitive, ROS-generating nanoreactorsACS Biomater Sci Eng201731024312442
   PubMed Web of Science ®Google Scholar
• GaoYChenYJiXXfJControlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticlesACS Nano20115129788979822070571
   PubMed Web of Science ®Google Scholar
• LiWZhangHAssarafYGOvercoming ABC transporter-mediated multidrug resistance: molecular mechanisms and novel therapeutic drug strategiesDrug Resist Updat201627142927449595
   PubMed Web of Science ®Google Scholar
• WangDXuXZhangKCodelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatmentInt J Nanomedicine20181318719829343957
   PubMed Web of Science ®Google Scholar
• SaadMGarbuzenkoOBMinkoTCo-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancerNanomedicine20083676177619025451
   PubMed Web of Science ®Google Scholar
• TaratulaOGarbuzenkoOSavlaRWangYAHeHMinkoTMultifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexesCurr Drug Deliv201181596921034421
   PubMed Web of Science ®Google Scholar
• LiJLiuJGuoNZhangXReversal of multidrug resistance in breast cancer MCF-7/ADR cells by h-R3-siMDR1-PAMAM complexesInt J Pharm2016511143644527444552
   PubMed Web of Science ®Google Scholar
• KesharwaniPGajbhiyeVJainNKA review of nanocarriers for the delivery of small interfering RNABiomaterials201233297138715022796160
   PubMed Web of Science ®Google Scholar
• MishraDKBalekarNMishraPKNanoengineered strategies for siRNA delivery: from target assessment to cancer therapeutic efficacyDrug Deliv Transl Res20177234635828050890
   PubMed Web of Science ®Google Scholar
• MengHMaiWXZhangHCodelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivoACS Nano201372994100523289892
   PubMed Web of Science ®Google Scholar
• LiuJLiJLiuNIn vitro studies of phospholipid-modified PAMAM-siMDR1 complexes for the reversal of multidrug resistance in human breast cancer cellsInt J Pharm20175301–229129928619457
   PubMed Web of Science ®Google Scholar
• AzarmiSRoaWHLöbenbergRTargeted delivery of nanoparticles for the treatment of lung diseasesAdv Drug Deliv Rev200860886387518308418
   PubMed Web of Science ®Google Scholar
• PoojaDKulhariHKunchaMImproving efficacy, oral bioavailability, and delivery of paclitaxel using protein-grafted solid lipid nanoparticlesMol Pharm201613113903391227696858
   PubMed Web of Science ®Google Scholar
• ZhouQTTangPLeungSSChanJGChanHKEmerging inhalation aerosol devices and strategies: where are we headed?Adv Drug Deliv Rev20147531724732364
   PubMed Web of Science ®Google Scholar
• TaratulaOKuzmovAShahMGarbuzenkoOBMinkoTNano-structured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNAJ Control Release2013171334935723648833
   PubMed Web of Science ®Google Scholar
• LamJKLiangWChanHKPulmonary delivery of therapeutic siRNAAdv Drug Deliv Rev201264111521356260
   PubMed Web of Science ®Google Scholar
• RoglianiPCalzettaLCoppolaAOptimizing drug delivery in COPD: the role of inhaler devicesRespir Med201712461428284323
   PubMed Web of Science ®Google Scholar
• Al-HallakMHSarfrazMKAzarmiSRoaWHFinlayWHLöbenbergRPulmonary delivery of inhalable nanoparticles: dry powder inhalersTher Deliv20112101313132422826885
   PubMedGoogle Scholar
• TanSJKiatwuthinonPRohYHKahnJSLuoDEngineering nanocarriers for siRNA deliverySmall20117784185621374801
   PubMed Web of Science ®Google Scholar
• AbdelazizHMGaberMAbd-ElwakilMMInhalable particulate drug delivery systems for lung cancer therapy: nanoparticles, microparticles, nanocomposites and nanoaggregatesJ Control Release201826937439229180168
   PubMed Web of Science ®Google Scholar
• NascimentoTLHillaireauHFattalENanoscale particles for lung delivery of siRNAJ Drug Deliv Sci Technol201222199108
   Web of Science ®Google Scholar
• Loira-PastorizaCTodoroffJVanbeverRDelivery strategies for sustained drug release in the lungsAdv Drug Deliv Rev201475819124915637
   PubMed Web of Science ®Google Scholar
• FioreVFLoftonMCRoser-PageSPolyketal microparticles for therapeutic delivery to the lungBiomaterials201031581081719846216
   PubMed Web of Science ®Google Scholar
• VanbeverRMintzesJDWangJFormulation and physical characterization of large porous particles for inhalationPharm Res199916111735174210571280
   PubMed Web of Science ®Google Scholar
• MenonJURavikumarPPiseAGyawaliDHsiaCCNguyenKTPolymeric nanoparticles for pulmonary protein and DNA deliveryActa Biomater20141062643265224512977
   PubMed Web of Science ®Google Scholar
• WangYZhuL-HChenA-ZXuQHongY-JWangS-BOne-step method to prepare PLLA porous microspheres in a high-voltage electrostatic anti-solvent processMaterials201695368
   PubMed Web of Science ®Google Scholar
• D’AngeloICasciaroBMiroAQuagliaFMangoniMLUngaroFOvercoming barriers in Pseudomonas aeruginosa lung infections: engineered nanoparticles for local delivery of a cationic antimicrobial peptideColloids Surf B Biointerfaces201513571772526340361
   PubMed Web of Science ®Google Scholar
• KayeRSPurewalTSAlparHOSimultaneously manufactured nano-in-micro (SIMANIM) particles for dry-powder modified-release delivery of antibodiesJ Pharm Sci200998114055406819189420
   PubMed Web of Science ®Google Scholar
• PriceDNStrombergLRKundaNKMuttilPIn vivo pulmonary delivery and magnetic-targeting of dry powder nano-in-microparticlesMol Pharm201714124741475029068693
   PubMedGoogle Scholar
• LeeHJKangJHLeeHGPreparation and physicochemical characterization of spray-dried and jet-milled microparticles containing bosentan hydrate for dry powder inhalation aerosolsDrug Des Devel Ther20161040174030
   PubMed Web of Science ®Google Scholar
• ChenA-ZTangNWangS-BKangY-QSongH-FInsulin-loaded poly-L-lactide porous microspheres prepared in supercritical CO2 for pulmonary drug deliveryJ Supercrit Fluids2015101117123
   Web of Science ®Google Scholar
• KankalaRKZhangYSWangSBLeeCHChenAZSupercritical fluid technology: an emphasis on drug delivery and related biomedical applicationsAdv Healthc Mater201761631
   Web of Science ®Google Scholar
• ChenBQKankalaRKChenAZInvestigation of silk fibroin nanoparticle-decorated poly(l-lactic acid) composite scaffolds for osteoblast growth and differentiationInt J Nanomedicine2017121877189028331312
   PubMed Web of Science ®Google Scholar
• MizunoTMohriKNasuSDanjoKOkamotoHDual imaging of pulmonary delivery and gene expression of dry powder inhalant by fluorescence and bioluminescenceJ Control Release2009134214915419100298
   PubMed Web of Science ®Google Scholar
• EsfandiariNProduction of micro and nano particles of pharmaceutical by supercritical carbon dioxideJ Supercrit Fluids2015100129141
   Web of Science ®Google Scholar
• RestaniRBSilvaASPiresRFNano-in-micro poxylated polyurea dendrimers and chitosan dry powder formulations for pulmonary deliveryPart Part Syst Charact20163311851858
   Web of Science ®Google Scholar
• SilvaASTavaresMTAguiar-RicardoASustainable strategies for nano-in-micro particle engineering for pulmonary deliveryJ Nanopart Res2014161117
   Web of Science ®Google Scholar
• AliMELamprechtASpray freeze drying for dry powder inhalation of nanoparticlesEur J Pharm Biopharm201487351051724657824
   PubMed Web of Science ®Google Scholar
• ChenA-ZKangY-QWangS-BTangNSuX-QXqSPreparation and antitumor effect evaluation of composite microparticles co-loaded with siRNA and paclitaxel by a supercritical processJ Mater Chem B201533164396447
   PubMed Web of Science ®Google Scholar
• ChenA-ZZhaoCWangS-BLiuY-GLinD-LGeneration of porous poly-L-lactide microspheres by emulsion-combined precipitation with a compressed CO2 antisolvent processJ Mater Chem B201312329672975
   PubMed Web of Science ®Google Scholar
• KangYQZhaoCChenAZStudy of lysozyme-loaded poly-L-lactide (PLLA) porous microparticles in a compressed CO2 antisolvent processMaterials2013683571358328811453
   PubMed Web of Science ®Google Scholar
• TakiMMarriottCZengXMMartinGPAerodynamic deposition of combination dry powder inhaler formulations in vitro: a comparison of three impactorsInt J Pharm20103881–2405120026261
   PubMedGoogle Scholar
• CuongN-VLiY-LHsiehM-FTargeted delivery of doxorubicin to human breast cancers by folate-decorated star-shaped PEG–PCL micelleJ Mater Chem201222310061020
   Web of Science ®Google Scholar
• HashadRAIshakRAFahmySMansourSGeneidiASChitosan-tripolyphosphate nanoparticles: optimization of formulation parameters for improving process yield at a novel pH using artificial neural networksInt J Biol Macromol201686505826783636
   PubMed Web of Science ®Google Scholar
• CsabaNKöping-HöggårdMAlonsoMJIonically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA deliveryInt J Pharm20093821–220521419660537
   PubMed Web of Science ®Google Scholar
• DasGNicastriAColuccioMLFT-IR, Raman, RRS measurements and DFT calculation for doxorubicinMicrosc Res Tech2010731099199520232462
   PubMed Web of Science ®Google Scholar
• ScjLOoiCPBoeyYCFRadiation effects on poly(lactide-co-glycolide) (PLGA) and poly(L-lactide) (PLLA)Polym Degradation Stab2004832259265
   Web of Science ®Google Scholar
• KimIByeonHJKimTHDoxorubicin-loaded highly porous large PLGA microparticles as a sustained-release inhalation system for the treatment of metastatic lung cancerBiomaterials201233225574558322579235
   PubMed Web of Science ®Google Scholar
• KimHLeeJKimTHAlbumin-coated porous hollow poly(lactic-co-glycolic acid) microparticles bound with palmityl-acylated exendin-4 as a long-acting inhalation delivery system for the treatment of diabetesPharm Res20112882008201921472489
   PubMed Web of Science ®Google Scholar
• KangYYangCOuyangPPingOYThe preparation of BSA-PLLA microparticles in a batch supercritical anti-solvent processCarbohydr Polym2009772244249
   Web of Science ®Google Scholar
• AlibolandiMAbnousKHadizadehFDextran-poly lactide-co-glycolide polymersomes decorated with folate-antennae for targeted delivery of docetaxel to breast adenocarcinima in vitro and in vivoJ Control Release2016241455627639681
   PubMed Web of Science ®Google Scholar
• GuoLLiuYBaiYSunYXiaoFGuoYGene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysisEur J Cancer20104691692170220371173
   PubMed Web of Science ®Google Scholar
• LinSDengFHuangPA novel legumain protease-activated micelle cargo enhances anticancer activity and cellular internalization of doxorubicinJ Mater Chem B201532960016012
   PubMed Web of Science ®Google Scholar
• RichardIThibaultMde CrescenzoGBuschmannMDLavertuMIonization behavior of chitosan and chitosan-DNA polyplexes indicate that chitosan has a similar capability to induce a proton-sponge effect as PEIBiomacromolecules20131461732174023675916
   PubMed Web of Science ®Google Scholar
• DengXCaoMZhangJHyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancerBiomaterials201435144333434424565525
   PubMed Web of Science ®Google Scholar
• FanYPLiaoJZLuYQYqLMiR-375 and doxorubicin co-delivered by liposomes for combination therapy of hepatocellular carcinomaMol Ther Nucleic Acids2017718118928624193
   PubMedGoogle Scholar